Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 2Vaginitis 1Urologic Neoplasms 1Urologic Diseases 1Sexuality 1Sexual Dysfunction, Physiological 1Hypogonadism 1Dyspareunia 1Castration-Resistant Prostate Carcinoma 1

Interventions

Surveys and Questionnaires 5Radiotherapy 3Counseling 3Therapeutics 2Psychiatric Rehabilitation 2Exercise 2trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1bicalutamide 1alectinib 1Vitamin E 1Vitamin D 1Uterine Myomectomy 1Testosterone Propionate 1Testosterone 1Sildenafil Citrate 1Sexual Health 1Sex Education 1Restraint, Physical 1Radiosurgery 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sexual Dysfunction, Physiological × Testosterone Propionate × Clear all
NCT00075855 2016-07-13

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Alliance for Clinical Trials in Oncology

Phase 3 Completed
150 enrolled
Other

Sexual Dysfunction, Physiological, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡